Navigation Links
American Society for Microbiology honors Walter Stamm
Date:7/14/2008

Washington, DCJune 25, 2008 The 2008 American Society for Microbiology (ASM) sanofi-aventis U.S. Award will be presented to Walter Stamm, Associate Director, WWAMI Regional Center of Excellence for Biodefense and Emerging Infectious Diseases, Seattle, Washington. Supported by an unrestricted grant from sanofi-aventis U.S., this award honors outstanding accomplishment in antimicrobial chemotherapy.

Through his professional life, Dr. Stamm has worked with antimicrobial resistance for urinary tract infections, chlamydia infections, and sexually transmitted infections. He is recognized as a leader in the antimicrobial therapy of urinary tract infections and has written guidelines for the therapy of chlamydia and other STIs for the Centers for Disease Control and Prevention. Dr. Stamm has published over 300 peer-reviewed papers, about 100 book chapters, and 11 books, most of them about urinary tract infections and genital infections including the role of bacterial pathogenesis, antimicrobial susceptibility and resistance. From 1999 through 2000, Dr. Stamm was a visiting scientist for the World Health Organization in the Antimicrobial Drug Resistance and Surveillance Branch.

Dr. Stamm received his B.A. in Biological Sciences from Stanford University and his M.D. from Harvard Medical School.. He completed his residency at the University of Washington.

The sanofi-aventis U.S. Award will be presented during ASM's 48th Interscience Conference on Antimicrobial Agents and Chemotherapy/46th IDSA Annual Meeting, October 25 October 28, 2008 in Washington, DC. ASM is the world's oldest and largest life science organization and has more than 43,000 members worldwide. ASM's mission is to advance the microbiological sciences and promote the use of scientific knowledge for improved health and economic and environmental well-being.


'/>"/>

Contact: Garth Hogan
ghogan@asmusa.org
American Society for Microbiology
Source:Eurekalert

Page: 1

Related biology news :

1. American Chemical Societys Weekly PressPac -- Aug. 8, 2007
2. Understanding hypertension in African Americans proves elusive
3. Tips from the Journals of the American Society for Microbiology
4. American Chemical Societys Weekly PressPac -- Aug. 15, 2007
5. American College of Medical Genetics responds to new FDA labeling decision for warfarin
6. American Chemical Societys Weekly Press Pac
7. Highlights from the September 2007 Journal of the American Dietetic Association
8. American Chemical Societys Weekly Presspac -- Aug. 29, 2007
9. Report: African, Asian, Latin American farm animals face extinction
10. American Chemical Society calls green chemistry bill a smart step
11. Challenges remain in reintroducing American chestnut
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... 27, 2017  Catholic Health Services (CHS) has ... Society (HIMSS) Analytics for achieving Stage 6 on ... . In addition, CHS previously earned a place ... an electronic medical record (EMR). "HIMSS ... of EMR usage in an outpatient setting.  This ...
(Date:3/23/2017)... , March 23, 2017 The report "Gesture Recognition ... Biometric), Industry, and Geography - Global Forecast to 2022", published by MarketsandMarkets, the ... a CAGR of 29.63% between 2017 and 2022. ... ... ...
(Date:3/22/2017)... YORK , March 21, 2017 ... Marketing Cloud used by retailers such as 1-800-Flowers ... its platform — Product Recommendations and Replenishment. Using Optimove,s ... give more personalized product and replenishment recommendations to ... but also on predictions of customer intent drawn ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... For today, Stock-Callers.com redirects investors, attention to Biotechnology, ... research aimed at treating diseases and medical conditions. Under evaluation ... (NASDAQ: KERX), Kite Pharma Inc. (NASDAQ: KITE), and ZIOPHARM Oncology ... complimentary research reports on these stocks now at: ... http://stock-callers.com/registration Biostage ...
(Date:4/19/2017)... ... April 19, 2017 , ... Nobilis Therapeutics ... Company Seeks to Leverage Clinical Data in its Upcoming Post Traumatic Stress Disorder Trial ... an 81 patient clinical trial assessing efficacy of its NBTX-001, a xenon-based therapeutic in ...
(Date:4/19/2017)... Calif. , April 19, 2017  As ... Drug Abuse and Heroin Summit ,  Proove® Biosciences, ... study analyzing genetics, environmental, and lifestyle factors to ... from the University of Southern California (USC), the ... , and Proove publish results showing that Proove ...
(Date:4/18/2017)... ... April 18, 2017 , ... ... Channel Partners 2017 Next-Gen Solution Provider. , Channel Partners program recognizes IT and ... their vision, innovation, and advocacy of the channel during transition and convergence. CallTower ...
Breaking Biology Technology: